Bristol Myers Squibb to Participate in Guggenheim’s Virtual Healthcare Talks | 2021 Oncology Day
February 05 2021 - 6:59AM
Business Wire
Bristol Myers Squibb (NYSE: BMY) today announced that the
company will take part in a fireside chat at Guggenheim’s Virtual
Healthcare Talks | 2021 Oncology Day, which will be webcast on
Friday, February 12, 2021. Chris Boerner, Ph.D., Executive Vice
President, Chief Commercial Officer will answer questions about the
company at 12 p.m. ET.
Investors and the general public are invited to listen to a live
webcast of the session at http://investor.bms.com. Material related
to the company’s presentation will be available at the same website
at the start of the live webcast. An archived edition of the
session will be available later that day.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter, YouTube, Facebook, and
Instagram.
CorporateFinancial-News
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210205005012/en/
Bristol Myers Squibb
Media: media@bms.com
Investor Relations:
Tim Power, 609-252-7509, timothy.power@bms.com Nina Goworek,
908-673-9711, nina.goworek@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024